OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and ...

OPK insiders have traded $OPK stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales. Here’s a ...

If you are looking for an AI stock that is more promising than OPK but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI ...

Opko Health's stock rating and outlook remain positive based on these recent developments within its subsidiary, ModeX Therapeutics. InvestingPro subscribers have access to 10 additional ...

OPKO Health is witnessing a positive estimate revision trend for 2024. In the past 60 days, the Zacks Consensus Estimate for its loss has narrowed from 26 cents to 23 cents per share.